(Q38592105)

4 September 2017

title

Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids (English)

1 reference

4 September 2017

Seul Min Choi

1

1 reference

4 September 2017

Byung-Mu Lee

series ordinal

2

1 reference

4 September 2017

language of work or name

English

0 references

publication date

24 September 2015

1 reference

Expert Opinion on Drug Safety

4 September 2017

published in

1 reference

4 September 2017

volume

14

1 reference

4 September 2017

issue

11

1 reference

4 September 2017

page(s)

1773-1785

1 reference

Molecular and cellular biology of interleukin-6 and its receptor

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Androgens in men--uses and abuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Sudden or unnatural deaths involving anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Discovery of nonsteroidal androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Androgen receptor (AR) coregulators: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Deciphering the selective androgen receptor modulators paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Pharmacology of anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Investigation, treatment and monitoring of late-onset hypogonadism in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

The impact of nandrolone decanoate on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Effect of Nandrolone Decanoate on serum lipoprotein (a) and its isoforms in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Advances in testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Comparative Safety of Testosterone Dosage Forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

The effects of 17 alpha-methyltestosterone, methandrostenolone, and nandrolone decanoate on the rat estrous cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Chronic administration of anabolic steroids disrupts pubertal onset and estrous cyclicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Sexualhormone X. Herstellung des 17-Methyl-testosterons und anderer Androsten- und Androstanderivate. Zusammenhänge zwischen chemischer Konstitution und männlicher Hormonwirkung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Effects of synthetic androgens on liver function using the rabbit as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Virilizing effect of methyltestosterone on female descendants in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Effects of acute stanozolol treatment on puberty in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Assay of stanozolol for tumor initiating and promoting activity in two rat liver foci bioassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Safety of testosterone use in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Adverse health effects of anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Chromosome damage and cytotoxicity in oral mucosa cells after 2 months of exposure to anabolic steroids (decadurabolin and winstrol) in weight lifting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Ischemic stroke related to anabolic abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Androgenic/Anabolic steroid-induced toxic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

The effect of anabolic steroids on the gastrointestinal system, kidneys, and adrenal glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Increased atherothrombotic markers and endothelial dysfunction in steroid users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

The safety of postmenopausal testosterone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Testosterone therapy and cardiovascular risk: advances and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Illicit anabolic-androgenic steroid use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Nuclear receptor coregulators: cellular and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Improving selective androgen receptor modulator discovery and preclinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Enobosarm (GTx-024, S-22): a potential treatment for cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Testosterone and prostate cancer: revisiting old paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Differing levels of testosterone and the prostate: a physiological interplay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Androgen receptor roles in the development of benign prostate hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

A selective androgen receptor modulator with minimal prostate hypertrophic activity restores lean body mass in aged orchidectomized male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

Enhancing effect of oxymetholone, an anabolic steroid, on development of liver cell foci in rats initiated with N-diethylnitrosamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2015.1094052

10.1517/14740338.2015.1094052

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference